Compare BioNTech SE - ADR (BNTX) vs Fox Corp Class A (FOXA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Fox Corp Class A — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Fox Corp Class A trades at $62.43 (market cap $24.58B). The key difference: BioNTech SE - ADR and Fox Corp Class A are close in size by market cap, and Fox Corp Class A pays a 0.93% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | FOXA | |
|---|---|---|
Market Cap | $23.31B | $24.58B |
Sector | Health | Media |
52-Week High | $119.34 | $76.11 |
52-Week Low | $83.89 | $48.79 |
Enterprise Value | $6.60B | $27.94B |
Dividend Yield | — | 0.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →
